ORAGENICS, INC. Unrealized Gain (Loss) on Derivatives and Commodity Contracts
ORAGENICS, INC. (OGEN) reported Unrealized Gain (Loss) on Derivatives and Commodity Contracts of $188.73 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-10-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivativesAndCommodityContracts · last filed 2017-10-31
- ORAGENICS, INC. unrealized gain (loss) on derivatives and commodity contracts for the quarter ending 2017-09-30 was -$42.92K.
| Period end | Unrealized Gain (Loss) on Derivatives and Commodity Contracts 3 month | Unrealized Gain (Loss) on Derivatives and Commodity Contracts 6 month | Unrealized Gain (Loss) on Derivatives and Commodity Contracts 9 month |
|---|---|---|---|
| 2017-09-30 | -$42.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $188.73K 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $231.64K 10-Q · filed 2017-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |